Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets
Glioblastoma (GBM) is an aggressive and highly malignant primary brain tumor characterized by rapid growth and a poor prognosis for patients. Despite advancements in treatment, the median survival time for GBM patients remains low. One of the crucial challenges in understanding and treating GBMs inv...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2024-09-01
|
| סדרה: | Cells |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2073-4409/13/18/1574 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
